Abstract | PURPOSE: To determine the therapeutic efficacy of a novel rare sugar, l- psicose, for the treatment of HSV-1 induced herpetic stromal keratitis (HSK) in a mouse eye model. METHODS: One rare sugar l- psicose was assayed for HSV-1 inhibition of in vitro virus adsorption. The IC50 and IC90 values of l- psicose were determined using plaque reduction assay (PRA) in CV-1 cell. Female Balb/c mice were corneally infected with HSV-1, strain KOS-GFP; A topical eye drop treatment of l- psicose was started 24 h after infection and continued four times daily for ten consecutive days. The severity of HSK was monitored by slit lamp examination in a masked fashion and Infectious HSV-1 shedding was determined by PRA. RESULTS: l- psicose was found to have anti-viral activity in vitro at an IC50 dose of 99.5 mM and an IC90 dose of 160 mM. Topical eye drop treatment with 200 mM l- psicose in PBS solution significantly reduced the severity of HSK compared to the mock treatment group. The in vivo mouse ocular model results of l- psicose therapy correlated with accelerated clearance of virus from eye swabs. CONCLUSION: The results suggest that topical treatment with rare sugar l- psicose has efficacy against HSK through inhibition of HSV-1.
|
Authors | Syed Muniruzzaman, Megan McIntosh, Ahamed Hossain, Ken Izumori, Partha S Bhattacharjee |
Journal | Journal of pharmacological sciences
(J Pharmacol Sci)
Vol. 131
Issue 2
Pg. 126-30
(Jun 2016)
ISSN: 1347-8648 [Electronic] Japan |
PMID | 27262904
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 The Authors. Production and hosting by Elsevier B.V. All rights reserved. |
Chemical References |
- Antiviral Agents
- psicose
- Fructose
|
Topics |
- Administration, Topical
- Animals
- Antiviral Agents
(administration & dosage, therapeutic use)
- Disease Models, Animal
- Eye
(drug effects, virology)
- Female
- Fructose
(administration & dosage, therapeutic use)
- Herpesvirus 1, Human
- Keratitis, Herpetic
(drug therapy)
- Mice, Inbred BALB C
- Mice, Inbred C57BL
|